BHI of Omsk region "Clinical oncological dispensary"

Omsk 644013

0 studies enrolling now · 3 studies all time

What they study most

Non-muscle Invasive Bladder Cancer, Prostate Cancer, Urothelial Cancer

Studies at this site

• Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC — Running, not enrolling
• A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer — Running, not enrolling
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed